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Introduction
Several components of the EGF receptor signal transduction pathway are phosphorylated when an EGF ligand binds to its receptor (for review see Schlessinger 2000) . In particular, autophosphorylation of the EGFR at specific intracellular tyrosine residues is critical for the subsequent signal transduction. Protein phosphatases may be part of a negative regulatory network that attenuates the activity of the EGFR/RAS/MAPK pathway. The genomes of both invertebrates and vertebrates encode a large number of predicted phosphatases genes (Bhaduri and Sowdhamini 2003; Alonso et al. 2004) . For example, the C. elegans genome contains at least 165 putative protein phosphatase genes (www.wormbase.org). However, the physiological substrates of most protein phosphatases have not yet been identified, as many experiments addressing this question were performed in vitro by overexpression, which impairs the substrate specificity of phosphatases (den Hertog 1999) . Only a few protein phosphatases have been assigned specific roles in developmental processes or signaling pathways through clear-cut loss-of-function genetics. Examples include the mouse PTP 1B that inhibits insulin receptor signaling (Elchebly et al. 1999) , Drosophila PTP-ER, which inhibits MAPK signaling during eye development (Karim and Rubin 1999) and C. elegans CLR-1, which inactivates the EGL-15 FGF receptor (Kokel et al. 1998 ). However, in many cases the identification and functional analysis of phosphatases is complicated by the fact that animals mutant for a single phosphatase gene display no obvious phenotype, suggesting that most protein phosphatases act redundantly with other modifiers (Harroch et al. 2000; Haj et al. 2003) .
Mammalian Dep1 is a member of the class III Receptor Protein Tyrosine Phosphatase (R-PTP) family (den Hertog 1999) . Dep-1 expression is induced in contact-inhibited cell cultures, hence the name Density-enhanced phosphatase 1 (Ostman et al. 1994) . Different receptor tyrosine kinases (RTKs) including c-Met, PDGFR and VEGFR-2 are Dep-1 substrates in vitro, but whether these RTKs are also in vivo substrates of Dep-1 is not known (Lampugnani et al. 2003; Jandt et al. 2003; Palka et al. 2003) . Interestingly, Dep-1 exhibits tumor suppressor activity when overexpressed in cultured tumor cells (Keane et al. 1996; Trapasso et al. 2000) , and the mouse Dep-1 gene was recently identified as the colon cancer susceptibility locus scc1 (Ruivenkamp et al. 2002) . Human Dep-1 is often mutated in colon, breast, skin and lung carcinomas (Ruivenkamp et al. 2002) . Despite its importance as tumor suppressor in various epithelial tissues, the biological functions of Dep-1 are not understood. Numerous questions remain to be answered to elucidate the role of Dep-1 in tumorigenesis, including the identification of physiological substrates and the role of Dep-1 in cell fate specification and pattern formation during normal development.
The development of the C. elegans hermaphrodite vulva serves as a paradigm to study how equivalent precursor cells can integrate the input from multiple signaling pathways to achieve a binary cell fate decision (Sundaram 2004) . During vulval induction, the anchor cell (AC) in the somatic gonad secretes the EGF-like growth factor LIN-3 to activate the EGFR/RAS/MAPK pathway in the adjacent vulval precursor cells (VPCs). The strength of the EGFR/RAS/MAPK signal in the VPCs depends on their distance from the AC (Yoo et al. 2004) . The VPC located closest to the AC, P6.p, exhibits highest RAS/MAPK activity and adopts the primary (1°) cell fate. The neighboring VPCs, P5.p and P7.p, exhibit intermediate levels of RAS/MAPK activity (Yoo et al. 2004) , and the distal VPCs P3.p, P4.p and P8.p that are further away from the AC display weak RAS/MAPK activity due to a relay signal generated by the proximal VPCs (Dutt et al. 2004) . However, by the time of vulval cell fate specification at the beginning of the L3 stage, a lateral signal from P6.p that is transduced by the DELTA/NOTCH signaling pathway inactivates the EGFR/RAS/MAPK pathway in P5.p and P7.p to prevent 1° cell fate specification and induce the secondary (2°) fate in these cells (Ambros 1999; Berset et al. 2001; Chen and Greenwald 2004; Yoo et al. 2004) . LIN-12 NOTCH signaling inhibits 1° fate specification in P5.p and P7.p by up-regulating the transcription of several negative regulators of the EGFR/RAS/MAPK signaling pathway such as lip-1, dpy-23 and the lst genes (Berset et al. 2001; Yoo et al. 2004 ). In particular, the dual-specificity phosphatase LIP-1, which is the homologue of vertebrate MKP-3, inactivates the MAP kinase MPK-1 to inhibit 1° fate specification in P5.p and P7.p (Berset et al. 2001 ). However, lip-1(lf) or lst RNA interference (RNAi) animals develop a morphologically wild-type vulva. Moreover, double mutants between lip-1(lf) and known inhibitors of the EGFR/RAS/MAPK signaling pathway such as unc-101 (Lee et al. 1994) , sli-1 (Yoon et al. 1995) , gap-1 (Hajnal et al. 1997) or ark-1 (Hopper et al. 2000) display no visible defects in lateral inhibition (T. Berset and A. Hajnal, unpublished results) . These observations suggested that lip-1 and the lst genes act redundantly with other inhibitors of the EGFR/RAS/MAPK pathway to achieve the binary, 1° versus 2° cell fate decision in the VPCs.
Here, we report the identification of the C. elegans R-PTP dep-1 in a genetic screen for genes that regulate the 1° versus 2° cell fate decision during vulval development. DEP-1 negatively regulates LET-23 EGFR signaling in the vulva and the excretory system in parallel with the MAPK phosphatases LIP-1 and independently of LIN-12 NOTCH. Similar to mutations in the mammalian Dep-1/Scc1 tumor suppressor gene, which alone are not sufficient to induce tumor formation (Ruivenkamp et al. 2002) , the developmental phenotypes of dep-1 only manifest in sensitized genetic backgrounds. Therefore, C. elegans vulval development serves as a genetic model to identify the homologs of mammalian tumor suppressor genes and study their genetic interactions with conserved signaling pathways.
Results

A genetic screen for adjacent primary cell fate mutants
To identify new genes that regulate the 1° versus 2° vulval cell fate decision in parallel with lip-1, we screened approximately 30'000 haploid genomes in a lip-1(lf) background for synthetic Adjacent primary cell fate (Apf) mutants using morphological criteria to identify animals with 2° to 1° cell fate transformations (Fig.1 A) .
Descendants of 1° vulval cells detach from the cuticula and migrate inwards (Katz et al. 1995) . In this way, we isolated a loss-of-function mutation (zh34) in a previously uncharacterized gene that we named dep-1 (see below). dep-1(lf); lip-1(lf) double mutants display a strong Apf and weak multivulva (Muv) phenotype, while dep-1(lf) or lip-1(lf) single mutants develop a wild-type vulva ( Fig.1 B to E, Tab. 1). A similar Apf nonMuv phenotype can by observed if the EGFR/RAS/MAPK pathway is hyperactivated after the first round of vulval cell divisions has occurred by overexpressing MPK-1 under the control of a heat shock-inducible promoter (Fig. 1 F and G, Tab.1) (Lackner and Kim 1998; Wang and Sternberg 1999 (Burdine et al. 1998; Yoo et al. 2004 ). In a wildtype background, dep-1(lf) does not cause ectopic egl-17::cfp expression, but in a let-60(gf) background dep-1(lf) increases the number of adjacent cells expressing egl-17::cfp (Fig. 1 N) . On the other hand, loss of dep-1 function does not significantly alter egl-17::cfp expression in a lip-1(lf) background (Fig. 1 N) (gf) background, in which all six VPCs adopt the 2° cell fate (Greenwald et al. 1983 (Greenwald et al. 1983) . However, gonad ablations demonstrated that vulval induction in dep-1(lf); lip-1(lf) animals can occur independently of the AC signal (Tab. 1). Thus, DEP-1 acts downstream of or in parallel with LIN-12 NOTCH to inhibit 1° fate specification.
dep-1 encodes a receptor protein tyrosine phosphatase
We identified F44G4.8 as the dep-1 locus by positional cloning ( 
DEP-1 inhibits LET-23 EGFR signaling
Next, we tested whether dep-1 negatively regulates the activity of the LET-23 EGFR during vulval induction. dep-1(lf) suppresses the vulvaless (Vul) phenotype caused by lin-7, lin-2 or lin-10 mutations, which reduce but do not eliminate the activity of let-23 egfr (Kaech et al. 1998) . (Clark et al. 1992) , is not suppressed by dep-1(lf) (Tab. 1).
Since wnt signaling promotes vulval cell fate specification in parallel to the EGFR/RAS/MAPK pathway we examined the interaction of dep-1 with wnt pathway mutants (Gleason et al. 2002) . A mutation in the ß-catenin bar-1 is not suppressed by dep-1(lf), indicating that DEP-1 does not act downstream of BAR-1. Furthermore, a mutation in the negative regulator of the wnt pathway pry-1 axin (Korswagen et al. 2002 ) causes a Muv phenotype but no ectopic egl-17::cfp expression (Fig. 1 N) .
Confirming the results of the epistasis analysis, we observed a physical interaction between DEP-1 and LET-23 EGFR in GST pull-down experiments (Fig. 3) . EGFR from whole animal extracts specifically bound to the intracellular domain of DEP-1 carrying a substrate-trapping mutation in the phosphatase domain (GST::DEP-1D 1241 A) that allows the catalytically inactive enzyme to remain bound to its phosphorylated substrate (Palka et al. 2003) .
On the other hand, neither wild-type DEP-1 (GST::DEP-1wt) nor GST alone bound to LET-23 EGFR. Taken together, these results indicate that DEP-1 inhibits inductive AC signaling by dephosphorylating LET-23 EGFR.
DEP-1::GFP is expressed in 2° vulval cells independently of the lateral LIN-12 NOTCH signal
To investigate the dep-1 expression pattern, we generated a transcriptional dep1p::gfp and a rescuing translational DEP-1::GFP reporter line ( Fig. 2 A and Tab.1).
Both reporters are expressed at the time of vulval induction at equal levels in P5.p, P6.p and P7.p (Fig. 4 A) . After the first round of cell divisions, the translational DEP-1::GFP reporter is down-regulated in the 1° lineage, but expression persists in the 2°v ulval cells until the L4 stage (Fig. 4 B to F; DEP-1::GFP expression is lower in P6.p than in P5.p or P7.p descendants in 82% of L3 and in 95% of L4 larvae, n=61 and n=21, respectively). A similar reduction of the expression in the 1° lineage is observed with the transcriptional reporter (Fig. 4 G, gfp expression is lower in P6.p than in P5.p or P7.p descendants in 80% of the L3 larvae, n=78). In most cases (e.g. 17 out of 18 larvae at the Pn.px and Pn.pxx stages), DEP-1::GFP expression is low or absent in cells expressing high LET-23 EGFR levels and vice versa (Fig. 4 E) .
Since the DEP-1::GFP expression pattern is very similar to that of a translational LIN-12::GFP reporter, we tested if dep-1 transcription is controlled by LIN-12 NOTCH (Levitan and Greenwald 1998; Shaye and Greenwald 2002 4 I, 89% of lin-12(lf) L3 larvae, n=37). In addition, no cluster of CSL sites characteristic of the known LIN-12 NOTCH targets can be found in regulatory region of dep-1 (Berset et al. 2001; Yoo et al. 2004 ). Thus, dep-1 is not a transcriptional target of the lateral DELTA/NOTCH signaling pathway.
EGFR signaling coordinately down-regulates DEP-1 and LIN-12 NOTCH expression in the 1° vulval cells
In lin-12(gf) animals, which lack an AC and hence produce no inductive signal (Greenwald et al. 1983) , dep-1p::gfp remains expressed in the P6.p descendants (Fig. 4 H Thus, the AC signal simultaneously down-regulates DEP-1 and LIN-12 NOTCH expression in the 1° vulval cells via the SUR-2 transcription factor (Fig. 6) .
DEP-1 regulates the binary cell fate choice in the excretory system
Finally, we examined whether DEP-1 regulates the specification of the duct cell fate in the excretory system, which is another example of a binary cell fate decision controlled by the EGFR/RAS/MAPK pathway (Fig. 5 A) (Yochem et al. 1997) . During embryonic development, one descendant of each the AB.pl and the AB.pr lineage has the potential to adopt the duct cell fate. In wild-type animals, the AB.pl descendant differentiates into the duct cell, while the AB.pr descendant adopts the G1 fate. ras gain-of-function mutants develop two duct cells, whereas ras loss-of-function mutants form two G1 cells (Fig. 5 A to E) . If the EGFR/RAS/MAPK pathway is inactivated in the AB.pl lineage, then the G1 precursor from the AB.pr lineage generates a duct cell, indicating that the duct cell or its precursor normally inhibits the G1 precursor from producing a duct cell (Yochem et al. 1997) . dep-1(lf); lip-1(lf) double mutants frequently display duct cell duplications as shown by the ectopic expression of the lin-48::gfp marker (Fig. 5 F, G and H) (Sewell et al. 2003) . In contrast, pry-1 axin(lf), bar-1(gf) and lin-12 notch(lf) mutants never have more than one duct cell, and lin-12(gf), glp-1 notch(gf) and bar-1(lf) mutants always contain a duct cell (Fig. 5 H) (Lambie and Kimble 1991) . Thus, neither the wnt nor the lin-12 notch pathways control duct cell fate specification. Therefore, dep-1 inhibits EGFR/RAS/MAPK signaling in the G1 precursor independently of the wnt and notch signals.
Discussion
DEP-1 specifically inhibits LET-23 EGFR signaling
We have identified the R-PTP DEP-1 in a forward genetic screen for genes that 
DEP-1 inhibits 1° cell fate specification in parallel with the LIN-12 NOTCH
C. elegans as a model to study tumor suppressor gene function
Our results establish C. elegans as a model to study the function of dep-1 during development, which may lead to an understanding of the molecular mechanism underlying the tumor suppressor activity of mammalian Dep-1. Loss of C. elegans dep-1 function alone does not cause a visible developmental defect, but it shifts the balance in the uncommitted VPCs from the 2° towards the 1° cell fate. Similarly, mutations in human Dep-1/Scc1 alone are not sufficient to induce oncogenic transformation, but they increase the likelihood of tumor development in various epithelial tissues, especially in the intestinal mucosa (Ruivenkamp et al. 2002) . In analogy to the function of C. elegans DEP-1, the defect leading to the formation of intestinal carcinomas may be a failure to restrict EGFR-stimulated cell proliferation in the epithelia. At the base of intestinal crypts, stem cells can either proliferate or differentiate into migratory enterocytes that leave the base of the crypts. Possibly, loss of DEP-1 function shifts this balance, leading to an accumulation of proliferating undifferentiated cells that may further develop into tumor cells.
Materials and Methods
General C. elegans methods and strains C. elegans strains were cultured at 20°C as described (Brenner 1974) . Wild-type refers to C. elegans variety Bristol, strain N2. The mutations used are listed below.
Unless noted otherwise, the mutations used have been described (Riddle 2001) .
Standard methods were used to construct double and triple mutants. Unless noted in the table legend, all experiments were conducted at 20°C. dep-1(zh34) was cis-linked with unc-4(e120) or bli-1(e769) to construct the double mutants shown in table 1. The induction of VPCs was scored at the L4 larval stage using Nomarski optics as described (Berset et al. 2001) . To ablate the gonad, the nuclei of the Z1 to Z4 gonad precursor cells were ablated in early L1 larvae with a laser microbeam as described (Kimble 1981) . The operated animals were allowed to develop until the L4 stage when successfully ablated animals, in which neither gonad arm had developed and no residual gonadal cells survived, were identified under Nomarski optics.
Alleles used:
LGI: lin-10(e1438), unc-13(e1091), unc-101(sy108), sur-2(ku9), pry-1(mu38) LGII: dep-1(zh34) (this study), lin-7(e1413), unc-4(e120), dpy-10(e128), bli-1(e769), let-23(sy1), rrf-3(pk1426) (Simmer et al. 2002 . LGIV:
lip-1(zh15) (Berset et al. 2001 , ark-1(sy247) (Hopper et al. 2000) LGX: sli-1(sy143) (Jongeward et al. 1995), gap-1(ga133) (Hajnal et al. 1997 , bar-1(ga80) (Eisenmann et al. 1998 ).
Transgenic arrays (transgene, co-transformation marker): saIs14 [lin-48::gfp, unc-119(+) ] (Sewell et al. 2003), arIs92[egl-17p::cfp-lacZ,unc-4(+) ] (Yoo et al. 2004 ),
gaIs36[HS-mpk-1(+),EF1alpha-D-mek(+)unc-30(+)] V (Lackner and Kim 1998),
zhIs10 [dep-1p-Δpes::nls::gfp::lacZ, unc-119(+) ] (this study); zhEx112 [dep-1::gfp, unc-119(+) ] (this study); zhEx113 [dep-1::gfp, lin-48::gfp] (Johnson et al. 2001); zhEx90[F44G4.8, sur-5::gfp] (this study).
Positional cloning of dep-1
Young adult lip-1(zh15) hermaphrodites were mutagenized with 50 mM Ethyl Methanesulfonate for 4 hours at room temperature, and the F2 generation was screened for mutants displaying an Apf phenotype. Approximately 30'000 haploid genomes were screened. dep-1(zh34); lip-1(zh15) mutants were backcrossed three times against Bristol N2, and chromosomal linkage of zh34 to LGII was determined by bulk-segregant analysis as described (Wicks et al. 2001) . Three factor mapping placed dep-1(zh34) between dpy-10 and unc-4, approximately at position 0.9. For high-resolution SNP mapping, unc4(e120) dep-1(zh34); lip-1(zh15) and dpy-10(e128) dep-1(zh34); lip-1(zh15) animals were crossed with the polymorphic mapping strain C. elegans CB4856 (Wicks et al. 2001) . Apf nonUnc and Apf nonDpy recombinants were isolated and F3 clones homozygous for the recombinant chromosome were established. Informative SNPs were selected from the C. elegans genome sequencing centre web site (http://genome.wustl.edu/). SNP analysis defined a region between snp_F37B12 and snp_T07D4 ( fig. 1 P) . RNAi analysis (see below) of the 54 of the predicted genes in this region in an rrf-3(pk1426); lip-1(zh15) background identified F44G4.8 as the candidate gene. Rescue experiments were performed as follows: 20.6 kb PCR products were amplified with TaKaRa LA Taq (TAKARA BIO INC) using the primers OTB57 (GGA TTT TGA ACC ATT GGG TCG) and OTB44 (ATG AGC TAC CCG TGG AAA CC) from the cosmid F44G4, pooled and tested for integrity by restriction enzyme digestion. 30ng/µl of purified PCR product were injected together with 50 ng/µl of pTG96 (sur-5::gfp) as transformation marker into wild-type animals, and three independent transgenic lines were crossed to dep-1(zh34); lip-1(zh15) mutants to assay for rescue. 
GFP reporter constructs
Transgenic animals
Transgenic animals were generated either by microinjection of DNA or by microparticle bombardment as described (Mello et al. 1991 ; Praitis et al. 2001) . Where indicated, extrachromosomal arrays were integrated into the genome by gammairradiation of L4 larvae. Integrated arrays were backcrossed at least five times before further analysis.
GST pull-down experiments
A cDNA fragment encoding the intracellular domain of DEP-1 (amino acids 925 to 1367) was cloned into the BamHI site of the E.coli expression vector pGEX-2TK (Pharmacia). The D 1241 to A mutation was introduced by site-directed mutagenesis using the Quick-change kit (Stratagene). Recombinant proteins were affinity-purified on glutathione sepharose beads according to the manufacturers protocol (Pharmacia), except that protein expression was induced in BL21 bacteria at 25°C, and fusion proteins were extracted in the presence of 0.1% Triton X100 and 450mM NaCl. Approximately 1 µg of each DEP-1 fusion protein and 10 µg of GST as negative control were used in each binding reaction. To prepare N2 worm extracts, mixed-stage cultures were washed 3 times with PBS, resuspended in lysis buffer (25mM Tris pH 7.5, 150 mM NaCl, 0.5% Triton X100, 10mM EDTA, 1x protease inhibitor cocktail (Roche)), homogenized with a douncer and centrifuged for 15 minutes at 4°C and 10000g to remove insoluble components. About 100µg of total protein extract was used in each reaction. Binding was performed at room temperature for 2 hours, the sepharose beads were washed 3 times with lysis buffer, and bound proteins were eluted by boiling the beads for 5 minutes in SDS gel-loading buffer. LET-23 was detected on Western blots of 10% acrylamide gels with polyclonal affinity-purified LET-23 antibody (Kaech et al. 1998) . Similar results were obtained using a monoclonal antibody raised against the same LET-23 epitope (data not shown).
Antibody staining and GFP expression studies
LET-23 antibody staining using a polyclonal antibody against the LET-23 Cterminus was performed as described in (Kaech et al. 1998) . GFP and CFP expression was observed under fluorescent light illumination with a Leica DMRA microscope equipped with a cooled CCD camera (Hamamatsu ORCA-ER) controlled by the Openlab 3.0 software package (Improvision). To score GFP expression in the Pn.p cells, animals were mounted on 3% agarose pads in M9 solution containing 15 mM NaN 3 . Larvae were first inspected using Nomarski optics to identify the position of the Pn.p cells or their descendants, and GFP expression was then scored under fluorescent light illumination using the same exposure settings for a particular transgene in all different genetic backgrounds.
RNAi interference
RNAi was performed by feeding worms with dsRNA-producing E.coli as described (Kamath et al. 2001 ) with the following modifications: 5 to 10 L1 larvae were placed on the RNAi plates, and the P0 and F1 generation were inspected for Apf phenotypes. 3mM IPTG was added to the agar to induce the expression of dsRNA. (A) Lineage relationship between the duct and G1 cells and phenotypes caused by let-60 ras mutations (adapted from (Yochem et al. 1997 
)). (B) Nomarski and (C)
GFP fluorescence image of the duct cell in a wild-type L3 larva carrying the LIN-48::GFP reporter (Sewell et al. 2003) . 
